Actualités Abpro Holdings Inc - ABP | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025

WOBURN, Mass., March 25, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing...

Abpro Statement on the Departure of Former CEO Ian Chan

WOBURN, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Abpro Holdings, Inc. (Nasdaq:ABP) ("Abpro"), a biotechnology company dedicated to advancing...

Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing

Business combination closed November 13, 2024Raised $10 million of gross proceeds in connection with the business combinationAgreements are in...

Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II

WOBURN, Mass. and NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Abpro Corporation (“Abpro”), a biotech company with the mission of improving the...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Abpro Holdings Inc (ABP)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

ABP Actualités

Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025

Abpro Statement on the Departure of Former CEO Ian Chan

Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing

Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II

Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets

C. K. Cooper & Company Announces Presenting Companies at Its 4th Annual Energy Conference

C. K. Cooper & Company Announces Departure of Phil McPherson

Tortoise Capital Resources Corp. Invests $7.5 Million in Abraxas Energy Partners, L.P.

American Stock Exchange to Trade Options on Seventeen Securities

Director Shareholding

Director Shareholding

Notice of Results

Holding(s) in Company

Director Shareholding

Director Shareholding

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Abpro Holdings Inc (ABP) Actualités

Abpro Holdings Inc (ABP)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

ABP Actualités

Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025

Abpro Statement on the Departure of Former CEO Ian Chan

Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing

Abpro Announces Filing of Registration Statement on Form S-4 in Connection with Business Combination Agreement with Atlantic Coastal Acquisition Corp. II

Abpro Forms Strategic Partnership to Advance Two Bispecific Antibody Candidates in Asian Markets

C. K. Cooper & Company Announces Presenting Companies at Its 4th Annual Energy Conference

C. K. Cooper & Company Announces Departure of Phil McPherson

Tortoise Capital Resources Corp. Invests $7.5 Million in Abraxas Energy Partners, L.P.

American Stock Exchange to Trade Options on Seventeen Securities

Director Shareholding

Director Shareholding

Notice of Results

Holding(s) in Company

Director Shareholding

Director Shareholding

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités